NEW YORK (GenomeWeb) – Metabolomic Diagnostics said this week it raised €750,000 ($848,000) in a second funding round that brings the total amount of investments in the firm to €1.5 million. 

Based in County Cork, Ireland, Metabolomic Dx is developing a predictive diagnostic test for the early detection of pre-eclampsia during pregnancy. The firm named SOSVentures Ireland Fund and AIB Seed Capital Fund as investors. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.